Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

12.26
-0.0100-0.08%
Post-market: 12.260.00000.00%16:10 EDT
Volume:1.12M
Turnover:13.71M
Market Cap:1.99B
PE:556.31
High:12.43
Open:12.30
Low:12.05
Close:12.27
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:0.77
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:8.24
PE(LYR):276.15

Loading ...

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

TIPRANKS
·
Aug 06

Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays

TIPRANKS
·
Aug 05

Vertex Inc. Earnings Call Shows Profitable Growth

TIPRANKS
·
Aug 05

Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live
·
Aug 05

Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Vertex Pharmaceuticals: Solid Q2 Beat and Raised 2026 Guidance, But Early-Stage Diversification and CRNX Integration Keep Rating at Hold

TIPRANKS
·
Aug 04

Vertex Upgraded to Buy as Strong Q2, Raised 2026 Guidance and Higher $605 Price Target Signal Durable, Diversified Growth

TIPRANKS
·
Aug 04

Vertex: Buy Rating Reaffirmed Amid Near-Term Demand Headwinds and Strategic Transformation, Price Target Maintained at $20

TIPRANKS
·
Aug 04

Vertex Analysts Lower Their Forecasts Following Q2 Results

Benzinga Earnings
·
Aug 04

Vertex Names Chatelle Lynch Chief People Officer in Leadership Expansion

Reuters
·
Aug 04

Press Release: Vertex Expands Leadership Team to Power the Next Chapter of Growth

Dow Jones
·
Aug 04

Vertex is Maintained at Outperform by Baird

Dow Jones
·
Aug 04

Vertex Inc : Bmo Raises Target Price to $15 from $14

THOMSON REUTERS
·
Aug 04

Vertex price target lowered to $17 from $19 at Baird

TIPRANKS
·
Aug 04

Cantor Fitzgerald Adjusts PT on Vertex Pharmaceuticals to $595 From $590, Maintains Overweight Rating

MT Newswires Live
·
Aug 04